or Try an Advanced Search...

    Human Monoclonal Antibodies Stocks List

    Symbol Grade Name % Change
    REGN C Regeneron Pharmaceuticals, Inc. -1.46
    XOMA C XOMA Corporation -1.31
    ARDS F Aridis Pharmaceuticals Inc. -14.39
    VCNX F Vaccinex, Inc. -7.44
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Antibodies Monoclonal Antibodies Immune System Immunology Infectious Diseases Medicine Antibody Biopharmaceutical Biotechnology Cardiovascular Disease Clinical Development Non Small Cell Lung Cancer Small Cell Lung Cancer Vascular Disease Acne Allergy Angiogenesis Antibody Product Asthma Atopic Dermatitis

    Related ETFs - A few ETFs which own one or more of the above listed Human Monoclonal Antibodies stocks.

    Symbol Grade Name Weight
    IBB D iShares Nasdaq Biotechnology Index Fund 8.22
    IBBQ C Invesco Nasdaq Biotechnology ETF 7.91
    BBH C Market Vectors Biotech ETF 7.81
    BIB C ProShares Ultra Nasdaq Biotechnology 5.63
    PJP B PowerShares Dynamic Pharmaceuticals 5.57
    View all Human Monoclonal Antibodies ETFs...
    Compare ETFs
    Compare BBH to PJP Compare IBB to BIB Compare IBB to IBBQ

        Human Monoclonal Antibodies Stocks Recent News

        Date Stock Title
        May 8 REGN Regeneron gene therapy improves hearing in child deafness
        May 8 REGN Regeneron gene therapy improves hearing in two children
        May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
        May 7 XOMA Certara, Inc. (CERT) Q1 Earnings Meet Estimates
        May 7 XOMA Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        May 6 REGN Regeneron Announces Investor Conference Presentations
        May 6 REGN Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
        May 5 REGN Wall Street Breakfast: The Week Ahead
        May 4 REGN 23 Most Profitable Stocks of the Last 12 Months
        May 3 REGN Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
        May 3 REGN Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
        May 3 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
        May 3 REGN Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
        May 2 REGN Regeneron Pharmaceuticals, Inc. (REGN) Q1 2024 Earnings Call Transcript
        May 2 REGN Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
        May 2 REGN Regeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say
        May 2 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
        May 2 REGN Regeneron Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 REGN Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
        May 2 REGN Regeneron falls after Q1 miss; announces $3B share buybacks
        Related Industries: Biotechnology
        Related Stock Lists: Antibodies Monoclonal Antibodies Immune System Immunology Infectious Diseases Medicine Antibody Biopharmaceutical Biotechnology Cardiovascular Disease Clinical Development Non Small Cell Lung Cancer Small Cell Lung Cancer Vascular Disease Acne Allergy Angiogenesis Antibody Product Asthma Atopic Dermatitis
        Human Monoclonal Antibodies

        Human monoclonal antibodies are laboratory-produced proteins that are designed to mimic the antibodies naturally produced by the human immune system. They are created by cloning a single antibody-producing B-cell, which produces identical copies of the same antibody. These antibodies are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases.

        Browse All Tags